Citadel Advisors - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26,133,220
+30.8%
765,024
+47.4%
0.01%
+25.0%
Q2 2023$19,978,113
-39.1%
518,912
-43.4%
0.00%
-42.9%
Q1 2023$32,831,384
-31.4%
917,334
-24.4%
0.01%
-36.4%
Q4 2022$47,832,809
+12.5%
1,213,107
+3.0%
0.01%
+22.2%
Q3 2022$42,507,000
-16.5%
1,177,502
-29.6%
0.01%
-30.8%
Q2 2022$50,916,000
+14.1%
1,673,739
+14.7%
0.01%
+44.4%
Q1 2022$44,606,000
+6.9%
1,459,180
+9.2%
0.01%
+12.5%
Q4 2021$41,734,000
+130.1%
1,335,903
+12.6%
0.01%
+100.0%
Q3 2021$18,137,000
-8.8%
1,186,916
+11.1%
0.00%0.0%
Q2 2021$19,885,000
+399.1%
1,067,943
+379.9%
0.00%
+300.0%
Q1 2021$3,984,000
+261.9%
222,552
+211.0%
0.00%
Q4 2020$1,101,000
-68.1%
71,550
-77.0%
0.00%
-100.0%
Q3 2020$3,451,000
-29.5%
311,682
-20.1%
0.00%
-50.0%
Q2 2020$4,894,000
-14.7%
390,260
-22.9%
0.00%
-33.3%
Q1 2020$5,738,000
+88.4%
506,029
+117.9%
0.00%
+200.0%
Q4 2019$3,045,000
+24.2%
232,265
-14.6%
0.00%0.0%
Q3 2019$2,452,000
-43.2%
272,085
-37.8%
0.00%
-50.0%
Q2 2019$4,315,000
-34.9%
437,580
-32.9%
0.00%
-33.3%
Q1 2019$6,625,000
+25.3%
652,023
-22.2%
0.00%0.0%
Q4 2018$5,289,000
-46.9%
838,302
+11.2%
0.00%
-25.0%
Q3 2018$9,952,000753,9350.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders